IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Evaluation of Outcomes Following LASIK Surgery Using CustomVue
This study has been completed.
Sponsor:
Medical University of South Carolina
Information provided by:
Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT00366769
First received: August 17, 2006
Last updated: NA
Last verified: March 2006
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of the study was to evaluate visual outcomes, contrast sensitivity, glare and induced high order aberrations induced by the new CustomVue software use for wavefront-guided LASIK.
| Condition | Intervention |
|---|---|
| Myopia Astigmatism Myopic Astigmatism | Device: Wavefront-guided LASIK using CustomVue platform |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment |
| Official Title: | Evaluation of Visual Outcomes, Contrast Sensitivity, Glare, and Induction of High Order Aberrations Following LASIK Surgery Using CustomVue |
Further study details as provided by Medical University of South Carolina:
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Myopia 0.00 to -6.00 D
- Astigmatism 0.00 up to -3.00 D
- Manifest refraction spherical equivalent (MRSE) up to -6.00 D.
Exclusion Criteria:
- History of ocular pathology
- Previous ocular surgery
- Large pupils (greater than 8mm diameter, infrared measurement)
- Thin corneas (preoperatively calculated minimal residual bed < 250 um)
- Irregular astigmatism
- Asymmetric astigmatism
- Unstable refraction
- Any other condition that precludes the patient from undergoing LASIK
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00366769
Please refer to this study by its ClinicalTrials.gov identifier: NCT00366769
Sponsors and Collaborators
Medical University of South Carolina
Investigators
| Principal Investigator: | Kerry D. Solomon, MD | Medical University of South Carolina |
More Information
| ClinicalTrials.gov Identifier: | NCT00366769 History of Changes |
| Other Study ID Numbers: |
MRC-05-005 |
| Study First Received: | August 17, 2006 |
| Last Updated: | August 17, 2006 |
Additional relevant MeSH terms:
|
Astigmatism Refractive Errors Eye Diseases |
ClinicalTrials.gov processed this record on September 21, 2017